Recent Advances in the Management of Severe Gastrointestinal Dysmotility

References

• Wingate D, Hongo M, Kellow J, Lindberg G, Smout A. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol. 2002;17(Suppl):S1–14. doi:10.1046/j.1440-1746.17.s1.7.x
   PubMed Web of Science ®Google Scholar
• Knowles CH, De Giorgio R, Kapur RP, et al. The London classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut. 2010;59(7):882–887. doi:10.1136/gut.2009.200444
   PubMed Web of Science ®Google Scholar
• Paine P, McLaughlin J, Lal S. Review article: the assessment and management of chronic severe gastrointestinal dysmotility in adults. Aliment Pharmacol Ther. 2013;38(10):1209–1229. doi:10.1111/apt.12496
   Web of Science ®Google Scholar
• Lindberg G, Iwarzon M, Tornblom H. Clinical features and long-term survival in chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol. 2009;44(6):692–699. doi:10.1080/00365520902839642
   PubMed Web of Science ®Google Scholar
• Vasant DH, Pironi L, Barbara G, et al. An international survey on clinicians’ perspectives on the diagnosis and management of chronic intestinal pseudo-obstruction and enteric dysmotility. Neurogastroenterol Motil. 2020;32(12):e13937. doi:10.1111/nmo.13937
   Web of Science ®Google Scholar
• Dibb M, Soop M, Teubner A, et al. Survival and nutritional dependence on home parenteral nutrition: three decades of experience from a single referral centre. Clin Nutr. 2017;36(2):570–576. doi:10.1016/j.clnu.2016.01.028
   PubMed Web of Science ®Google Scholar
• Smith T, Hirst A, Jones B, Baxter J. Annual BANS report. British Association of Parenteral and Enteral Nutrition; 2011.
   Google Scholar
• Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247–307.
   PubMed Web of Science ®Google Scholar
• Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011;60(1):17–25. doi:10.1136/gut.2010.223255
   PubMed Web of Science ®Google Scholar
• Nightingale JM, Paine P, McLaughlin J, Emmanuel A, Martin JE, Lal S. The management of adult patients with severe chronic small intestinal dysmotility. Gut. 2020;69(12):2074–2092. doi:10.1136/gutjnl-2020-321631
   Web of Science ®Google Scholar
• Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut. 1997;41(5):675–681. doi:10.1136/gut.41.5.675
   Web of Science ®Google Scholar
• Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of Gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261. doi:10.1053/j.gastro.2016.03.035
   PubMed Web of Science ®Google Scholar
• Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant Proc. 2010;42(1):15–18. doi:10.1016/j.transproceed.2009.12.017
   Web of Science ®Google Scholar
• Camilleri M. Intestinal dysmotility: does the X-ray resolve the real dilemma? J Pediatr Gastroenterol Nutr. 1997;24(1):100–101. doi:10.1097/00005176-199701000-00020
   Web of Science ®Google Scholar
• Quigley EM. Enteric dysmotility: validating the Wingate/Bangkok classification. Gastroenterology. 2010;139(1):346–348. doi:10.1053/j.gastro.2010.05.031
   Google Scholar
• Vasant DH, Kalaiselvan R, Ablett J, et al. The chronic intestinal pseudo-obstruction subtype has prognostic significance in patients with severe gastrointestinal dysmotility related intestinal failure. Clin Nutr. 2018;37(6):1967–1975. doi:10.1016/j.clnu.2018.09.008
   Web of Science ®Google Scholar
• Elfadil O, Velapati S, Hurt R, Lal S, Mundi M. Utility of sub-classification of severe gastrointestinal dysmotility in chronic intestinal failure. Clin Nutr ESPEN. 2020;40:531. doi:10.1016/j.clnesp.2020.09.373
   Google Scholar
• Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options. Neurogastroenterol Motil. 2017;29(1).
   Web of Science ®Google Scholar
• Malagelada C, Karunaratne TB, Accarino A, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil. 2017.
   Web of Science ®Google Scholar
• Billiauws L, Corcos O, Joly F. Dysmotility disorders: a nutritional approach. Curr Opin Clin Nutr Metab Care. 2014;17(5):483–488. doi:10.1097/MCO.0000000000000095
   Web of Science ®Google Scholar
• Farmer AD, Scott SM, Hobson AR. Gastrointestinal motility revisited: the wireless motility capsule. United European Gastroenterol J. 2013;1(6):413–421. doi:10.1177/2050640613510161
   Web of Science ®Google Scholar
• Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8–23. doi:10.1111/j.1365-2982.2010.01612.x
   PubMed Web of Science ®Google Scholar
• Rao SS, Mysore K, Attaluri A, Valestin J. Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility. J Clin Gastroenterol. 2011;45(8):684–690. doi:10.1097/MCG.0b013e3181ff0122
   Web of Science ®Google Scholar
• Roland BC, Ciarleglio MM, Clarke JO, et al. Small intestinal transit time is delayed in small intestinal bacterial overgrowth. J Clin Gastroenterol. 2015;49(7):571–576. doi:10.1097/MCG.0000000000000257
   Web of Science ®Google Scholar
• Farmer AD, Wegeberg AL, Brock B, et al. Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study country. Aliment Pharmacol Ther. 2018;47(3):391–400. doi:10.1111/apt.14438
   Web of Science ®Google Scholar
• Fuyuki A, Ohkubo H, Higurashi T, et al. Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction: a retrospective study of 33 patients. J Gastroenterol. 2017;52(5):577–584. doi:10.1007/s00535-016-1251-8
   Web of Science ®Google Scholar
• Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo‐obstruction and healthy controls. Neurogastroenterol Motil. 2016;28(3):376–383. doi:10.1111/nmo.12735
   Web of Science ®Google Scholar
• van Rijn KL, Bredenoord AJ, Smout AJPM, et al. Fasted and fed small bowel motility patterns at cine-MRI in chronic intestinal pseudo-obstruction. Neurogastroenterol Motil. 2020:e14062.
   Web of Science ®Google Scholar
• Knowles CH, Veress B, Tornblom H, et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil. 2008;20(7):774–779. doi:10.1111/j.1365-2982.2008.01099.x
   Web of Science ®Google Scholar
• Lindberg G, Tornblom H, Iwarzon M, Nyberg B, Martin JE, Veress B. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut. 2009;58(8):1084–1090. doi:10.1136/gut.2008.148296
   PubMed Web of Science ®Google Scholar
• Sinagra E, Pellegatta G, Maida M, et al. Could chronic idiopatic intestinal pseudo-obstruction be related to viral infections? J Clin Med. 2021;10(2):268. doi:10.3390/jcm10020268
   PubMed Web of Science ®Google Scholar
• Lam CY, Palsson OS, Whitehead WE, et al. Rome IV functional gastrointestinal disorders and health impairment in subjects with hypermobility spectrum disorders or hypermobile Ehlers-Danlos Syndrome. Clin Gastroenterol Hepatol. 2020. doi:10.1016/j.cgh.2020.02.034
   Web of Science ®Google Scholar
• Fikree A, Aktar R, Grahame R, et al. Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: a case–control study. Neurogastroenterol Motil. 2015;27(4):569–579. doi:10.1111/nmo.12535
   Web of Science ®Google Scholar
• Beckers AB, Keszthelyi D, Fikree A, et al. Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: a review for the gastroenterologist. Neurogastroenterol Motil. 2017;29(8):e13013. doi:10.1111/nmo.13013
   Web of Science ®Google Scholar
• Alomari M, Hitawala A, Chadalavada P, et al. Prevalence and predictors of gastrointestinal dysmotility in patients with hypermobile Ehlers-Danlos syndrome: a tertiary care center experience. Cureus. 2020;12(4).
   Web of Science ®Google Scholar
• Amiot A, Joly F, Cazals-Hatem D, et al. Prognostic yield of esophageal manometry in chronic intestinal pseudo-obstruction: a retrospective cohort of 116 adult patients. Neurogastroenterol Motil. 2012;24(11):1008–e1542. doi:10.1111/j.1365-2982.2012.01973.x
   Web of Science ®Google Scholar
• Maurer AH, Yu D, Lu X, et al. Addition of small-bowel transit scintigraphy to gastric emptying for assessment of patients with upper gastrointestinal symptoms. Neurogastroenterol Motil. 2021;33(2):e13987. doi:10.1111/nmo.13987
   Web of Science ®Google Scholar
• Schäppi M, Smith V, Milla P, Lindley K. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut. 2003;52(5):752–755. doi:10.1136/gut.52.5.752
   Web of Science ®Google Scholar
• Ooms AH, Verheij J, Hulst JM, et al. Eosinophilic myenteric ganglionitis as a cause of chronic intestinal pseudo-obstruction. Virchows Archiv. 2012;460(1):123–127. doi:10.1007/s00428-011-1183-x
   Web of Science ®Google Scholar
• Oton E, Moreira V, Redondo C, et al. Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy? Gut. 2005;54(9):1343–1344. doi:10.1136/gut.2005.071811
   Web of Science ®Google Scholar
• Dewit S, De Hertogh G, Geboes K, Tack J. Chronic intestinal pseudo‐obstruction caused by an intestinal inflammatory myopathy: case report and review of the literature. Neurogastroenterol Motil. 2008;20(4):343–348. doi:10.1111/j.1365-2982.2007.01033.x
   Web of Science ®Google Scholar
• Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SSC. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther. 2013;37(11):1103–1111. doi:10.1111/apt.12304
   PubMed Web of Science ®Google Scholar
• Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology. Gut. 2018;67(8):1380–1399. doi:10.1136/gutjnl-2017-315909
   PubMed Web of Science ®Google Scholar
• Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112(5):775. doi:10.1038/ajg.2017.46
   PubMed Web of Science ®Google Scholar
• Pimentel M, Saad RJ, Long MD, Rao SS. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165–178. doi:10.14309/ajg.0000000000000501
   PubMed Web of Science ®Google Scholar
• Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001;120(2):354–360. doi:10.1053/gast.2001.21166
   PubMed Web of Science ®Google Scholar
• Corsetti M, Thys A, Harris A, et al. High‐resolution manometry reveals different effect of polyethylene glycol, bisacodyl, and prucalopride on colonic motility in healthy subjects: an acute, open label, randomized, crossover, reader‐blinded study with potential clinical implications. Neurogastroenterol Motil. 2020:e14040.
   Web of Science ®Google Scholar
• Carbone F, Vanuytsel T, Tack J. The effect of prucalopride on gastric sensorimotor function and satiation in healthy volunteers. Neurogastroenterol Motil. 2021:e14083.
   Web of Science ®Google Scholar
• Carbone F, Van den Houte K, Clevers E, et al. Prucalopride in gastroparesis: a randomized placebo-controlled crossover study. Am J Gastroenterol. 2019;114(8):1265–1274. doi:10.14309/ajg.0000000000000304
   PubMed Web of Science ®Google Scholar
• Andrews CN, Woo M, Buresi M, et al. Prucalopride in diabetic and connective tissue disease‐related gastroparesis: randomized placebo‐controlled crossover pilot trial. Neurogastroenterol Motil. 2021;33(1):e13958. doi:10.1111/nmo.13958
   PubMed Web of Science ®Google Scholar
• Emmanuel A, Kamm M, Roy A, Kerstens R, Vandeplassche L. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo‐obstruction–a double‐blind, placebo‐controlled, cross‐over, multiple n= 1 study. Aliment Pharmacol Ther. 2012;35(1):48–55. doi:10.1111/j.1365-2036.2011.04907.x
   PubMed Web of Science ®Google Scholar
• Keefer L, Drossman DA, Guthrie E, et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology. 2016;150(6):1408–1419. doi:10.1053/j.gastro.2016.02.034
   Web of Science ®Google Scholar
• Kilgallon E, Vasant DH, Green D, et al. Chronic continuous abdominal pain: evaluation of diagnostic features, iatrogenesis and drug treatments in a cohort of 103 patients. Aliment Pharmacol Ther. 2019;49(10):1282–1292. doi:10.1111/apt.15241
   Web of Science ®Google Scholar
• Sobin WH, Heinrich TW, Drossman DA. Central neuromodulators for treating functional GI disorders: a primer. Am J Gastroenterol. 2017;112(5):693–702. doi:10.1038/ajg.2017.57
   Web of Science ®Google Scholar
• Drossman DA, Tack J, Ford AC, Szigethy E, Tornblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (Disorders of Gut-Brain Interaction): a Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140–1171 e1141. doi:10.1053/j.gastro.2017.11.279
   PubMed Web of Science ®Google Scholar
• Perlemuter G, Cacoub P, Chaussade S, Wechsler B, Couturier D, Piette JC. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. Arthritis Rheum. 1999;42(7):1545–1549. doi:10.1002/1529-0131(199907)42:7<1545::AID-ANR30>3.0.CO;2-T
   PubMed Web of Science ®Google Scholar
• Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325(21):1461–1467. doi:10.1056/NEJM199111213252102
   PubMed Web of Science ®Google Scholar
• Ambartsumyan L, Flores A, Nurko S, Rodriguez L. Utility of octreotide in advancing enteral feeds in children with chronic intestinal pseudo-obstruction. Pediatric Drugs. 2016;18(5):387–392. doi:10.1007/s40272-016-0189-x
   Web of Science ®Google Scholar
• Bharucha AE, Camilleri M, Burton D, Low PA, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008;18(4):194–202. doi:10.1007/s10286-008-0476-x
   PubMed Web of Science ®Google Scholar
• O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12(6):540–548. doi:10.1111/j.1463-1318.2009.01838.x
   Web of Science ®Google Scholar
• Bharucha AE, Low P, Camilleri M, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013;62(5):708. doi:10.1136/gutjnl-2012-302483
   PubMed Web of Science ®Google Scholar
• Ahuja NK, Mische L, Clarke JO, Wigley FM, McMahan ZH Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis. Paper presented at: Seminars in arthritis and rheumatism; 2018.
   Google Scholar
• Paine P, McMahon M, Farrer K, Overshott R, Lal S. Jejunal feeding: when is it the right thing to do? Frontline Gastroenterol. 2020;11(5):397–403. doi:10.1136/flgastro-2019-101181
   Web of Science ®Google Scholar
• Twist K, Ablett J, Wearden A, et al. Gastrointestinal dysmotility: a qualitative exploration of the journey from symptom onset to diagnosis. Neurogastroenterol Motil. 2018;30(8):e13339. doi:10.1111/nmo.13339
   Web of Science ®Google Scholar
• Ablett J, Vasant DH, Taylor M, Cawley C, Lal S. Poor social support and unemployment are associated with negative affect in home parenteral nutrition-dependent patients with chronic intestinal failure. J Parenter Enteral Nutr. 2019;43(4):534–539. doi:10.1002/jpen.1457
   Web of Science ®Google Scholar
• Amiot A, Joly F, Alves A, Panis Y, Bouhnik Y, Messing B. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol. 2009;104(5):1262–1270. doi:10.1038/ajg.2009.58
   Web of Science ®Google Scholar
• Salazar E, Clermont‐Dejean NM, Schwenger KJ, et al. Patients with severe gastrointestinal dysmotility disorders on home parenteral nutrition have similar survival as those with short bowel syndrome: a Prospective Cohort Study. J Parenter Enteral Nutr. 2020. doi:10.1002/jpen.1866
   Web of Science ®Google Scholar
• Appleby R, Yu C, Nightingale J. PTU-106  improved survival and independance from parental nutrition for patients with intestinal dysmotility. Gut. 2016;65(Suppl 1):A107–A107. doi:10.1136/gutjnl-2016-312388.192
   Web of Science ®Google Scholar
• Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol. 2005;3(5):449–458. doi:10.1016/S1542-3565(04)00675-5
   Web of Science ®Google Scholar
• Murr MM, Sarr MG, Camilleri M. The surgeon’s role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol. 1995;90(12).
   Web of Science ®Google Scholar
• Mughal M, Irving M. Treatment of end stage chronic intestinal pseudo-obstruction by subtotal enterectomy and home parenteral nutrition. Gut. 1988;29(11):1613–1617. doi:10.1136/gut.29.11.1613
   Web of Science ®Google Scholar
• Sogawa H, Costa G, Armanyous S, et al. Twenty years of Gut transplantation for chronic intestinal pseudo-obstruction: technical innovation, long-term outcome, quality of life, and disease recurrence. Ann Surg. 2021;273(2):325–333. doi:10.1097/SLA.0000000000003265
   PubMed Web of Science ®Google Scholar
• Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol. 2018;15(3):168. doi:10.1038/nrgastro.2017.141
   PubMed Web of Science ®Google Scholar
• Keefer L, Palsson OS, Pandolfino JE. Best practice update: incorporating psychogastroenterology into management of digestive disorders. Gastroenterology. 2018;154(5):1249–1257. doi:10.1053/j.gastro.2018.01.045
   PubMed Web of Science ®Google Scholar
• Riehl ME, Kinnucan JA, Chey WD, Stidham RW. Nuances of the psychogastroenterology patient: a predictive model for gastrointestinal quality of life improvement. Neurogastroenterol Motil. 2019;31(9):e13663. doi:10.1111/nmo.13663
   Web of Science ®Google Scholar
• Vasant DH, Whorwell PJ. Gut‐focused hypnotherapy for functional gastrointestinal disorders: evidence‐base, practical aspects, and the Manchester protocol. Neurogastroenterol Motil. 2019;31(8):e13573. doi:10.1111/nmo.13573
   PubMed Web of Science ®Google Scholar